Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal metabolic characteristics of Smilax china L. pectic polysaccharide and prediction of its gut microbiota-mediated mechanism.

International journal of biological macromolecules·2026
Same author

Chronic Low-Dose Cadmium Exposure Impairs Adult Hippocampal Neurogenesis by Suppressing Noncanonical Wnt5a Signaling.

Journal of applied toxicology : JAT·2026
Same author

Flexible Porous Pomelo Pith Derived Janus Liquid Metal and Adhesive Hydrogel Hybrid Electronic Skins.

Smart medicine·2026
Same author

Sprayable bioadhesive microcarriers loaded with Tβ4-Engineered ADSC exosomes for diabetic wound healing.

Bioactive materials·2026
Same author

Biomimetic adhesive hydrogel microcarriers for gas therapy and chemotherapy of gastric cancer.

Acta biomaterialia·2026
Same author

Mutation of a conserved lysine in the RdRp fingers domain broadly attenuates orthobunyaviruses.

Communications biology·2026

Related Experiment Video

Updated: Jul 11, 2025

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Engineering Heterogeneous Tumor Models for Biomedical Applications.

Zhuhao Wu1, Danqing Huang1, Jinglin Wang1

  • 1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|November 10, 2023
PubMed
Summary

Engineered tumor models can mimic cancer in vitro, but struggle with heterogeneity. This review explores methods to build better tumor models for cancer research and therapy.

Keywords:
drug screeningmicrofluidicsorgan-on-a-chiptissue engineeringtumor heterogeneitytumor models

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Related Experiment Videos

Last Updated: Jul 11, 2025

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Tissue Engineering

Background:

  • Tumor tissue engineering aims to replicate in vitro tumor characteristics for research.
  • Current tumor models lack sufficient reconstruction of tumor heterogeneity, hindering widespread adoption.
  • Tumor heterogeneity encompasses signaling pathways, cell proliferation, and spatial configurations.

Purpose of the Study:

  • To review the progress in engineering heterogeneous tumor models.
  • To summarize components of tumor heterogeneity and contemporary engineering approaches.
  • To discuss characterization, applications, challenges, and future directions for engineered tumor models.

Main Methods:

  • Summarizing major components of tumor heterogeneity.
  • Elucidating contemporary tumor engineering approaches guided by tumor biology principles.
  • Highlighting the potential of bottom-up approaches in tumor engineering.

Main Results:

  • Engineered tumor models offer new opportunities for studying the tumor microenvironment and anti-cancer therapeutics.
  • Characterization approaches and biomedical applications of tumor models are discussed.
  • The significant role of engineered tumor models in scientific research and clinical trials is emphasized.

Conclusions:

  • Addressing challenges in heterogeneous tumor models is crucial for advancing oncology research and tumor therapy.
  • Future research should focus on improving the understanding and reconstruction of tumor heterogeneity.
  • Engineered heterogeneous tumor models hold significant promise for future cancer research and treatment development.